NUS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NU Skin Enterprises Inc (NUS) is not a good buy for a beginner investor with a long-term strategy at this time. The stock exhibits bearish technical indicators, weak financial performance, and lacks any significant positive catalysts or trading signals. The investor should consider other opportunities with stronger growth potential and positive sentiment.
The technical indicators for NUS are bearish. The MACD histogram is negative (-0.105) and contracting, RSI is neutral at 20.782, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 7.554), with resistance levels at R1: 8.712 and R2: 9.069. Historical trends suggest a 70% chance of a decline in the next day (-0.8%), week (-0.28%), and month (-1.99%).
No positive catalysts identified. Gross margin increased by 12.91% YoY to 70.74%, which is a small positive but insufficient to outweigh the negatives.
There is no recent news or significant trading trends from hedge funds, insiders, or Congress. The stock lacks momentum, and options data shows minimal trading activity.
In Q4 2025, the company's financials showed significant declines: revenue dropped to $370.32M (-16.89% YoY), net income dropped to $14.49M (-140.14% YoY), and EPS fell to $0.29 (-139.73% YoY). Gross margin increased to 70.74% (+12.91% YoY), but this improvement does not offset the overall weak performance.
No recent analyst ratings or price target changes available for NUS. Wall Street sentiment appears neutral to negative, given the lack of significant activity or upgrades.
